These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38424744)

  • 1. Substantial Burden of Nonmedically Attended RSV Infection in Healthy-Term Infants: An International Prospective Birth Cohort Study.
    Hak SF; Venekamp RP; Billard MN; van Houten MA; Pollard AJ; Heikkinen T; Cunningham S; Millar M; Martinón-Torres F; Dacosta-Urbieta A; Bont LJ; Wildenbeest JG;
    J Infect Dis; 2024 Mar; 229(Supplement_1):S40-S50. PubMed ID: 38424744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study.
    Wildenbeest JG; Billard MN; Zuurbier RP; Korsten K; Langedijk AC; van de Ven PM; Snape MD; Drysdale SB; Pollard AJ; Robinson H; Heikkinen T; Cunningham S; O'Neill T; Rizkalla B; Dacosta-Urbieta A; Martinón-Torres F; van Houten MA; Bont LJ;
    Lancet Respir Med; 2023 Apr; 11(4):341-353. PubMed ID: 36372082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory Syncytial Virus Consortium in Europe (RESCEU) Birth Cohort Study: Defining the Burden of Infant Respiratory Syncytial Virus Disease in Europe.
    Wildenbeest JG; Zuurbier RP; Korsten K; van Houten MA; Billard MN; Derksen-Lazet N; Snape MD; Drysdale SB; Robinson H; Pollard AJ; Heikkinen T; Cunningham S; Leach A; Martinón-Torres F; Rodríguez-Tenreiro Sánchez C; Gómez-Carballa A; Bont LJ;
    J Infect Dis; 2020 Oct; 222(Suppl 7):S606-S612. PubMed ID: 32794574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic burden and health-related quality-of-life among infants with respiratory syncytial virus infection: A multi-country prospective cohort study in Europe.
    Mao Z; Li X; Dacosta-Urbieta A; Billard MN; Wildenbeest J; Korsten K; Martinón-Torres F; Heikkinen T; Cunningham S; Snape MD; Robinson H; Pollard AJ; Postma M; Dervaux B; Hens N; Bont L; Bilcke J; Beutels P;
    Vaccine; 2023 Apr; 41(16):2707-2715. PubMed ID: 36941154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised controlled trials.
    Simões EAF; Madhi SA; Muller WJ; Atanasova V; Bosheva M; Cabañas F; Baca Cots M; Domachowske JB; Garcia-Garcia ML; Grantina I; Nguyen KA; Zar HJ; Berglind A; Cummings C; Griffin MP; Takas T; Yuan Y; Wählby Hamrén U; Leach A; Villafana T
    Lancet Child Adolesc Health; 2023 Mar; 7(3):180-189. PubMed ID: 36634694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis.
    Li Y; Wang X; Blau DM; Caballero MT; Feikin DR; Gill CJ; Madhi SA; Omer SB; Simões EAF; Campbell H; Pariente AB; Bardach D; Bassat Q; Casalegno JS; Chakhunashvili G; Crawford N; Danilenko D; Do LAH; Echavarria M; Gentile A; Gordon A; Heikkinen T; Huang QS; Jullien S; Krishnan A; Lopez EL; Markić J; Mira-Iglesias A; Moore HC; Moyes J; Mwananyanda L; Nokes DJ; Noordeen F; Obodai E; Palani N; Romero C; Salimi V; Satav A; Seo E; Shchomak Z; Singleton R; Stolyarov K; Stoszek SK; von Gottberg A; Wurzel D; Yoshida LM; Yung CF; Zar HJ; ; Nair H;
    Lancet; 2022 May; 399(10340):2047-2064. PubMed ID: 35598608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burden of respiratory syncytial virus infection in community-dwelling older adults in Europe (RESCEU): an international prospective cohort study.
    Korsten K; Adriaenssens N; Coenen S; Butler C; Ravanfar B; Rutter H; Allen J; Falsey A; Pirçon JY; Gruselle O; Pavot V; Vernhes C; Balla-Jhagjhoorsingh S; Öner D; Ispas G; Aerssens J; Shinde V; Verheij T; Bont L; Wildenbeest J;
    Eur Respir J; 2021 Apr; 57(4):. PubMed ID: 33060153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries.
    Simoes EA; Carbonell-Estrany X
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S13-8; discussion S18-20. PubMed ID: 12671448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial.
    O'Brien KL; Chandran A; Weatherholtz R; Jafri HS; Griffin MP; Bellamy T; Millar EV; Jensen KM; Harris BS; Reid R; Moulton LH; Losonsky GA; Karron RA; Santosham M;
    Lancet Infect Dis; 2015 Dec; 15(12):1398-408. PubMed ID: 26511956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and economic burden of respiratory syncytial virus in Spanish children: the BARI study.
    Martinón-Torres F; Carmo M; Platero L; Drago G; López-Belmonte JL; Bangert M; Díez-Domingo J; Garcés-Sánchez M
    BMC Infect Dis; 2022 Sep; 22(1):759. PubMed ID: 36175846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory Syncytial Virus-Associated Hospital Admissions and Bed Days in Children <5 Years of Age in 7 European Countries.
    Wang X; Li Y; Vazquez Fernandez L; Teirlinck AC; Lehtonen T; van Wijhe M; Stona L; Bangert M; Reeves RM; Bøås H; van Boven M; Heikkinen T; Klint Johannesen C; Baraldi E; Donà D; Tong S; Campbell H;
    J Infect Dis; 2022 Aug; 226(Suppl 1):S22-S28. PubMed ID: 35023567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medically Attended Illness due to Respiratory Syncytial Virus Infection Among Infants Born in the United States Between 2016 and 2020.
    Gantenberg JR; van Aalst R; Zimmerman N; Limone B; Chaves SS; La Via WV; Nelson CB; Rizzo C; Savitz DA; Zullo AR
    J Infect Dis; 2022 Aug; 226(Suppl 2):S164-S174. PubMed ID: 35968869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of respiratory syncytial virus in a community birth cohort of infants in the first 2 years of life.
    Takashima MD; Grimwood K; Sly PD; Lambert SB; Chappell KJ; Watterson D; Ware RS
    Eur J Pediatr; 2021 Jul; 180(7):2125-2135. PubMed ID: 33634335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and Viral Factors Associated With Disease Severity and Subsequent Wheezing in Infants With Respiratory Syncytial Virus Infection.
    McGinley JP; Lin GL; Öner D; Golubchik T; O'Connor D; Snape MD; Gruselle O; Langedijk AC; Wildenbeest J; Openshaw P; Nair H; Aerssens J; Bont L; Martinón-Torres F; Drysdale SB; Pollard AJ;
    J Infect Dis; 2022 Aug; 226(Suppl 1):S45-S54. PubMed ID: 35902389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and economic hospital burden of acute respiratory infection (BARI) due to respiratory syncytial virus in Spanish children, 2015-2018.
    Martinón-Torres F; Carmo M; Platero L; Drago G; López-Belmonte JL; Bangert M; Díez-Domingo J
    BMC Infect Dis; 2023 Jun; 23(1):385. PubMed ID: 37291530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Socioeconomic Burden of Respiratory Syncytial Virus Infection in Children.
    Heikkinen T; Ojala E; Waris M
    J Infect Dis; 2017 Jan; 215(1):17-23. PubMed ID: 27738052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new cost-utility analysis assessing risk factor-guided prophylaxis with palivizumab for the prevention of severe respiratory syncytial virus infection in Italian infants born at 29-35 weeks' gestational age.
    Keary IP; Ravasio R; Fullarton JR; Manzoni P; Lanari M; Paes BA; Carbonell-Estrany X; Baraldi E; Tarride JÉ; Rodgers-Gray B
    PLoS One; 2023; 18(8):e0289828. PubMed ID: 37561741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating the impact of multiple immunization products on medically-attended respiratory syncytial virus (RSV) infections in infants.
    Rainisch G; Adhikari B; Meltzer MI; Langley G
    Vaccine; 2020 Jan; 38(2):251-257. PubMed ID: 31740097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent recurring wheezing in the fifth year of life after laboratory-confirmed, medically attended respiratory syncytial virus infection in infancy.
    Escobar GJ; Masaquel AS; Li SX; Walsh EM; Kipnis P
    BMC Pediatr; 2013 Jun; 13():97. PubMed ID: 23782528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High concentrations of amniotic fluid proinflammatory cytokines in healthy neonates are associated with low risk of respiratory syncytial virus bronchiolitis.
    Houben ML; Rovers MM; Wilbrink B; Belderbos ME; Bloemen-Carlier EM; Visser GH; Kimpen JL; Bont L
    Pediatr Infect Dis J; 2012 Sep; 31(9):931-4. PubMed ID: 22699404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.